Details

Correlation of the high-resolution computed tomography patterns of intrathoracic sarcoidosis with serum levels of SAA, CA 15.3, SP-D, and other biomarkers of interstitial lung disease
ID Leštan Ramovš, Zala (Author), ID Sodin-Šemrl, Snežna (Author), ID Lakota, Katja (Author), ID Čučnik, Saša (Author), ID Manevski, Damjan (Author), ID Zbačnik, Rok (Author), ID Zupančič, Mirjana (Author), ID Verbič, Martin (Author), ID Terčelj-Zorman, Marjeta (Author)

.pdfPDF - Presentation file, Download (3,19 MB)
MD5: 08A9544388FB532CEA521737C0AF4892
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/24/13/10794 This link opens in a new window

Abstract
Studies on the serum biomarkers of granulomatous inflammation and pulmonary interstitial disease in intrathoracic sarcoidosis have shown conflicting results. We postulated that differences in the concentrations of serum biomarkers can be explained by the heterogenous patterns of sarcoidosis seen on thoracic HRCT. Serum biomarker levels in 79 consecutive patients, newly diagnosed with intrathoracic sarcoidosis, were compared to our control group of 56 healthy blood donors. An analysis was performed with respect to HRCT characteristics (the presence of lymph node enlargement, perilymphatic or peribronchovascular infiltrates, ground-glass lesions, or fibrosis), CXR, and disease extent. Serum levels of CXCL9, CXCL10, CTO, and CCL18 were statistically significantly increased in all patients compared to controls. Serum levels of CA15.3 were statistically significantly increased in all patients with parenchymal involvement. SAA was increased in patients with ground-glass lesions while SP-D levels were statistically significantly increased in patients with lung fibrosis. Only SP-D and CA15.3 showed a significant correlation to interstitial disease extent. In conclusion, we found that sarcoidosis patients with different HRCT patterns of intrathoracic sarcoidosis have underlying biochemical differences in their serum biomarkers transcending Scadding stages. The stratification of patients based on both radiologic and biochemical characteristics could enable more homogenous patient selection for further prognostic studies.

Language:English
Keywords:intrathoracic sarcoidosis, biomarker, HRCT
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:15 str.
Numbering:Vol. 24, iss. 13, art. 10794
PID:20.500.12556/RUL-187755 This link opens in a new window
UDC:616.2
ISSN on article:1422-0067
DOI:10.3390/ijms241310794 This link opens in a new window
COBISS.SI-ID:157564931 This link opens in a new window
Publication date in RUL:15.09.2026
Views:7
Downloads:2
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:intratorakalna sarkoidoza, biomarker, HRCT

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back